Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma

Joseph M. Herman, Katherine Y. Fan, Aaron T. Wild, Laura D. Wood, Amanda L. Blackford, Ross C. Donehower, Manuel Hidalgo, Richard D. Schulick, Barish H. Edil, Michael A. Choti, Ralph H. Hruban, Timothy M. Pawlik, John L. Cameron, Daniel A. Laheru, Christine A. Iacobuzio-Donahue, Christopher L. Wolfgang

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma'. Together they form a unique fingerprint.